BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

236 related articles for article (PubMed ID: 30763790)

  • 1. Comprehensive Toxicity Assessment of PEGylated Magnetic Nanoparticles for in vivo applications.
    Caro C; Egea-Benavente D; Polvillo R; Royo JL; Pernia Leal M; García-Martín ML
    Colloids Surf B Biointerfaces; 2019 May; 177():253-259. PubMed ID: 30763790
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Long-circulating PEGylated manganese ferrite nanoparticles for MRI-based molecular imaging.
    Pernia Leal M; Rivera-Fernández S; Franco JM; Pozo D; de la Fuente JM; García-Martín ML
    Nanoscale; 2015 Feb; 7(5):2050-9. PubMed ID: 25554363
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Tailor-made PEG coated iron oxide nanoparticles as contrast agents for long lasting magnetic resonance molecular imaging of solid cancers.
    Lazaro-Carrillo A; Filice M; Guillén MJ; Amaro R; Viñambres M; Tabero A; Paredes KO; Villanueva A; Calvo P; Del Puerto Morales M; Marciello M
    Mater Sci Eng C Mater Biol Appl; 2020 Feb; 107():110262. PubMed ID: 31761230
    [TBL] [Abstract][Full Text] [Related]  

  • 4. One-pot facile synthesis of PEGylated superparamagnetic iron oxide nanoparticles for MRI contrast enhancement.
    Dai L; Liu Y; Wang Z; Guo F; Shi D; Zhang B
    Mater Sci Eng C Mater Biol Appl; 2014 Aug; 41():161-7. PubMed ID: 24907749
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Magnetic nanoparticles for precision oncology: theranostic magnetic iron oxide nanoparticles for image-guided and targeted cancer therapy.
    Zhu L; Zhou Z; Mao H; Yang L
    Nanomedicine (Lond); 2017 Jan; 12(1):73-87. PubMed ID: 27876448
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Selective contrast agents with potential to the earlier detection of tumors: Insights on synthetic pathways, physicochemical properties and performance in MRI assays.
    Montiel Schneider MG; Martin MJ; Coral DF; Muraca D; Gentili C; Fernández van Raap M; Lassalle VL
    Colloids Surf B Biointerfaces; 2018 Oct; 170():470-478. PubMed ID: 29960215
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Amorphous silica coatings on magnetic nanoparticles enhance stability and reduce toxicity to in vitro BEAS-2B cells.
    Baber O; Jang M; Barber D; Powers K
    Inhal Toxicol; 2011 Aug; 23(9):532-43. PubMed ID: 21819260
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Physico-chemical and toxicological characterization of iron-containing albumin nanoparticles as platforms for medical imaging.
    Rosenberger I; Schmithals C; Vandooren J; Bianchessi S; Milani P; Locatelli E; Israel LL; Hübner F; Matteoli M; Lellouche JP; Franchini MC; Passoni L; Scanziani E; Opdenakker G; Piiper A; Kreuter J
    J Control Release; 2014 Nov; 194():130-7. PubMed ID: 25173842
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Superparamagnetic cobalt ferrite nanoparticles as
    Mohammadi Z; Attaran N; Sazgarnia A; Shaegh SAM; Montazerabadi A
    IET Nanobiotechnol; 2020 Jul; 14(5):396-404. PubMed ID: 32691742
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Small versus Large Iron Oxide Magnetic Nanoparticles: Hyperthermia and Cell Uptake Properties.
    Iacovita C; Florea A; Dudric R; Pall E; Moldovan AI; Tetean R; Stiufiuc R; Lucaciu CM
    Molecules; 2016 Oct; 21(10):. PubMed ID: 27754394
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Development of PEGylated KMnF3 nanoparticles as a T1-weighted contrast agent: chemical synthesis, in vivo brain MR imaging, and accounting for high relaxivity.
    Liu ZJ; Song XX; Tang Q
    Nanoscale; 2013 Jun; 5(11):5073-9. PubMed ID: 23640287
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Efficient MRI labeling of endothelial progenitor cells: design of thiolated surface stabilized superparamagnetic iron oxide nanoparticles.
    Shahnaz G; Kremser C; Reinisch A; Vetter A; Laffleur F; Rahmat D; Iqbal J; Dünnhaupt S; Salvenmoser W; Tessadri R; Griesser U; Bernkop-Schnürch A
    Eur J Pharm Biopharm; 2013 Nov; 85(3 Pt A):346-55. PubMed ID: 23481176
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The cytotoxicity of polycationic iron oxide nanoparticles: common endpoint assays and alternative approaches for improved understanding of cellular response mechanism.
    Hoskins C; Cuschieri A; Wang L
    J Nanobiotechnology; 2012 Apr; 10():15. PubMed ID: 22510488
    [TBL] [Abstract][Full Text] [Related]  

  • 14. A Functional Iron Oxide Nanoparticles Modified with PLA-PEG-DG as Tumor-Targeted MRI Contrast Agent.
    Xiong F; Hu K; Yu H; Zhou L; Song L; Zhang Y; Shan X; Liu J; Gu N
    Pharm Res; 2017 Aug; 34(8):1683-1692. PubMed ID: 28608138
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Paclitaxel-Loaded Magnetic Nanoparticles: Synthesis, Characterization, and Application in Targeting.
    Tian J; Yan C; Liu K; Tao J; Guo Z; Liu J; Zhang Y; Xiong F; Gu N
    J Pharm Sci; 2017 Aug; 106(8):2115-2122. PubMed ID: 28456728
    [TBL] [Abstract][Full Text] [Related]  

  • 16. High-Performance Worm-like Mn-Zn Ferrite Theranostic Nanoagents and the Application on Tumor Theranostics.
    Sun Y; Yan C; Xie J; Yan D; Hu K; Huang S; Liu J; Zhang Y; Gu N; Xiong F
    ACS Appl Mater Interfaces; 2019 Aug; 11(33):29536-29548. PubMed ID: 31333014
    [TBL] [Abstract][Full Text] [Related]  

  • 17. A value-added exopolysaccharide as a coating agent for MRI nanoprobes.
    Palma SI; Rodrigues CA; Carvalho A; Morales Mdel P; Freitas F; Fernandes AR; Cabral JM; Roque AC
    Nanoscale; 2015 Sep; 7(34):14272-83. PubMed ID: 26186402
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Smart Design of a pH-Responsive System Based on pHLIP-Modified Magnetite Nanoparticles for Tumor MRI.
    Demin AM; Pershina AG; Minin AS; Brikunova OY; Murzakaev AM; Perekucha NA; Romashchenko AV; Shevelev OB; Uimin MA; Byzov IV; Malkeyeva D; Kiseleva E; Efimova LV; Vtorushin SV; Ogorodova LM; Krasnov VP
    ACS Appl Mater Interfaces; 2021 Aug; 13(31):36800-36815. PubMed ID: 34324807
    [TBL] [Abstract][Full Text] [Related]  

  • 19. A facile microwave synthetic route for ferrite nanoparticles with direct impact in magnetic particle hyperthermia.
    Makridis A; Chatzitheodorou I; Topouridou K; Yavropoulou MP; Angelakeris M; Dendrinou-Samara C
    Mater Sci Eng C Mater Biol Appl; 2016 Jun; 63():663-70. PubMed ID: 27040263
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Manganese ferrite-based nanoparticles induce ex vivo, but not in vivo, cardiovascular effects.
    Nunes AD; Ramalho LS; Souza AP; Mendes EP; Colugnati DB; Zufelato N; Sousa MH; Bakuzis AF; Castro CH
    Int J Nanomedicine; 2014; 9():3299-312. PubMed ID: 25031535
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.